All Products are stable to be shipped at room temperature, unless otherwise specified.
| Pack Size | Quantity | Price (USD) | Sub Total |
|---|---|---|---|
| 5mg | $ 125.00 | 0.0 | |
| 10mg | $ 180.00 | 0.0 | |
| 25mg | $ 305.00 | 0.0 | |
| 100mg | $ 495.00 | 0.0 | |
| Exact Weight Packaging | $ 75.00 | 0.0 | |
| Total | $ 0.0 | ||
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : In Stock
- Ships On :
M199800
Bulk Order Request for M199800
Product Description
| Catalogue Number | M199800 |
| Chemical Name | MDV 3100 (Enzalutamide) |
| Synonyms | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; MDV3100; MDV-3100; Enzalutamide; |
| CAS Number | 915087-33-1 |
| Molecular Formula | C₂₁H₁₆F₄N₄O₂S |
| Appearance | White to Off-White Solid |
| Melting Point | 198 - 200°C |
| Molecular Weight | 464.44 |
| Storage | Refrigerator |
| Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated) |
| Category | Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer. |
| References | Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); |